Literature DB >> 4815902

Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU).

J Lokich, P L Chawla, J Brooks, E Frei.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4815902      PMCID: PMC1355995          DOI: 10.1097/00000658-197404000-00012

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Disappearance of disseminated pancreatic carcinoma with combined chemotherapy.

Authors:  J J Lokich; J R Brooks
Journal:  Ann Surg       Date:  1973-01       Impact factor: 12.969

2.  Metastatic insulinoma treated with streptozotocin.

Authors:  P H Schreibman; L G De Koliren; R A Arky
Journal:  Ann Intern Med       Date:  1971-03       Impact factor: 25.391

3.  Cancer of the pancreas.

Authors:  I A Bouchier
Journal:  Br Med J       Date:  1968-07-20

4.  Combination chemotherapy in gastrointestinal cancer.

Authors:  R J Reitemeier; C G Moertel; R G Hahn
Journal:  Cancer Res       Date:  1970-05       Impact factor: 12.701

5.  Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

Authors:  C G Moertel; D S Childs; R J Reitemeier; M Y Colby; M A Holbrook
Journal:  Lancet       Date:  1969-10-25       Impact factor: 79.321

6.  The rising incidence of carcinoma of the pancreas. An epidemiologic appraisal.

Authors:  L S Krain
Journal:  Am J Gastroenterol       Date:  1970-11       Impact factor: 10.864

7.  Combination therapy with 5-fluorouracil (5-FU; NSC-19893) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for disseminated gastrointestinal carcinoma.

Authors:  J J Lokich; A T Skarin
Journal:  Cancer Chemother Rep       Date:  1972-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.